Garside, Deborah A and Gebril, Ayman M and Alsaadi, Manal and Nimmo, Natalie and Mullen, Alexander and Ferro, Valerie (2013) An update on the potential for male contraception : emerging options. Open Access Journal of Contraception, 2013 (4).
OAJC_30380_an_update_on_the_potential_for_male_contraception_emerging_041013.pdf - Final Published Version
Download (346kB) | Preview
The human population continues to grow and is estimated to rise to 10.1 billion by the end of the century. Therefore, there is still an unmet need for safe and highly effective contraceptive options for both men and women. Current options available to men include withdrawal, condoms, and vasectomy. Methods in development fall into two categories: hormonal and nonhormonal. This review will provide an overview of the testosterone combinations and immunocontraception of hormonal targets. Nonhormonal immunocontraception of sperm proteins will also be examined, together with the use of agents to disrupt other sperm-associated targets and pathways. The categories focused on include epididymal proteins, testicular kinases, epigenetic reader proteins, opioids, lonidamine derivatives, retinoic acid, microRNAs associated with spermatogenesis, and plant extracts. Considering these developments, the number of options available to men is likely to increase in the near future.
|Keywords:||contraception, male contraception, nonhormonal contraceptives, hormonal, immunocontraception, Pharmacy and materia medica|
|Subjects:||Medicine > Pharmacy and materia medica|
|Department:||Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences
Faculty of Engineering > Biomedical Engineering
|Depositing user:||Pure Administrator|
|Date Deposited:||06 Mar 2013 09:23|
|Last modified:||31 Mar 2017 14:53|